The Shs8 Trillion US-Uganda Health Deal and the Pivot to ‘Self-Reliance’
In a landmark yet intensely scrutinized development, the governments of Uganda and the United States have signed a five-year Memorandum of Understanding (MoU) on bilateral health cooperation, valued at approximately $2.3 billion (about Shs8 trillion). Signed on December 10, 2025, in Kampala, the pact is touted by both nations as a pivotal shift towards strengthening Uganda’s health system and achieving self-reliance. However, the sheer size of the deal and the context of its signing have placed it at the center of a national controversy, prompting calls for financial accountability and scrutiny over data sovereignty.
A Landmark Co-Investment Model
The new bilateral health cooperation agreement outlines a comprehensive plan to bolster health financing, digital health systems, disease prevention, and support for public health programs across the country from 2026 to 2030. The total value of the cooperation, estimated at $2.3 billion, is structured as a co-investment:
- US Commitment: The United States pledges up to $1.7 billion (over Shs6 trillion) to support critical health programs. These funds are earmarked for long-running priority areas, including HIV/Aids (under PEPFAR), tuberculosis, malaria (PMI), maternal and child health, global health security, disease surveillance, and emergency preparedness.
- Uganda’s Pledge: In a key departure from traditional aid models, the Government of Uganda has pledged to increase its domestic health expenditure by more than $500 million (Shs1.7 trillion) during the same period. This commitment is intended to gradually build Uganda’s capacity to assume greater financial responsibility for its national health system, a central goal of the new framework.
A joint statement emphasized that the co-investment model aims to sustain past health gains while simultaneously empowering Uganda to take greater ownership of its health agenda.
A Funding Crisis
The main reason the deal is viewed as “controversial” lies in the sudden and dramatic withdrawal of U.S. health aid that immediately preceded the MoU negotiations.
In January 2025, following a U.S. presidential executive order, Uganda experienced an abrupt freeze and loss of approximately Shs604 billion in funding for essential services. This was a catastrophic blow to a sector heavily reliant on foreign assistance—U.S. funding alone accounted for 55% of the country’s total HIV/AIDS response.
The aid withdrawal instantly created a massive funding shortfall in Uganda’s health sector, estimated at over Shs1.7 trillion by the Ministry of Health. This vacuum threatened to reverse decades of progress, particularly in the fight against HIV/AIDS, with reports surfacing that anti-retroviral therapy (ART) facilities were operating at reduced capacity and some HIV testing services had stopped entirely.
In response, the Ugandan Parliament was forced to approve a supplementary budget of Shs503 billion to cushion the sector, borrowing heavily from domestic and external sources to prevent immediate drug stock outs and a full-blown health crisis. Critics argue that the new $2.3 billion co-investment pact, while massive, effectively mandates Uganda to shoulder a financial burden that was primarily created by the abrupt withdrawal of the very funds it is now replacing. This forces an immediate domestic borrowing or revenue increase in a sector already struggling with underfunding.
Data Sharing and Sovereignty Concerns
Another element of the controversy is a stipulation in the MoU that reportedly obligates Uganda to share vital health data with the United States. While officials argue this is necessary for shared global health security and data-driven decision-making, it has raised concerns among some political analysts and civil society organizations regarding:
- Data Sovereignty: Who ultimately owns and controls the sensitive medical and epidemiological data of Ugandan citizens?
- External Influence: Whether the sharing of this data could lead to undue external influence over national health priorities, including policy and budgetary allocations.
The US Envoy’s Position
Addressing the intensity of the debate, U.S. Ambassador to Uganda, H.E. William W. Popp, has actively spoken out to defend the new framework, describing it not as a resumption of aid, but as a fundamental transformation of the partnership.
In his remarks, Ambassador Popp emphasized that the agreement is a reaffirmation of the long-standing commitment between the two nations and marks a “pivotal shift toward Ugandan self-reliance.” He stressed that the goal is to build a more resilient and sustainable health system by integrating strong community health systems and clear performance metrics.
Popp highlighted that the new model builds on prior successes in disease control and improved maternal health, but focuses explicitly on the future: accelerating gains and building a health system that is future-proof. By requiring a $500 million increase in domestic spending, the deal forces Uganda to integrate health funding into its national budget cycle, ultimately making the system less vulnerable to the political decisions of external partners.
Conclusion
The Shs8 trillion health deal places Uganda at a critical juncture. On one hand, it represents a necessary injection of funds and expertise to continue the fight against endemic and emerging diseases. On the other hand, the controversial context—the immediate need for funds following the U.S. aid freeze—has led to intense public debate over whether the co-investment model is a genuine partnership or a new form of conditioned dependency, forcing Uganda to borrow and share data in exchange for the restoration of essential services. For the country’s health policymakers, the challenge now lies in effectively utilizing the immense resources while safeguarding national interests and ensuring the promised path to self-reliance is achieved.
